| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |